Targeted core-shell nanoparticles for precise CTCF gene insert in treatment of metastatic breast cancer-Reference-Cited by-同舟云学术

Targeted core-shell nanoparticles for precise CTCF gene insert in treatment of metastatic breast cancer

Published:2022-05 Issue: Volume:11 Page:1-14
ISSN:2452-199X
Container-title:Bioactive Materials
language:en
Short-container-title:Bioactive Materials

Author:

Duan Jialun,Bao Chunjie,Xie Ying^ORCID,Guo Haitao,Liu Yixuan,Li Jianwei,Liu Rui,Li Peishan,Bai Jing,Yan Yan,Mu Limin,Li Xueqi,Wang Guiling,Lu Wanliang

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Publisher

Elsevier BV

Subject

Biomedical Engineering,Biomaterials,Biotechnology

Reference50 articles.

1. Breast cancer statistics, 2013;DeSantis;Ca - Cancer J. Clin.,2014

2. Treatment of low-risk ductal carcinoma in situ: is nothing better than something?;Benson;Lancet Oncol.,2016

3. Breast cancer treatment: a review;Waks;J. Am. Med. Assoc.,2019

4. Breast cancer;Harbeck;Lancet,2016

5. Breast cancer;Harbeck;Nat. Rev. Dis. Primers,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy;Bioactive Materials;2024-04

2. Tumor-derived mesenchymal progenitor cell-related genes in the regulation of breast cancer proliferation;Gland Surgery;2024-03

3. Amphiphilic multi-targeting copolymer micelles efficiently deliver pZNF580 to promote endothelial cell proliferation and migration;Journal of Materials Chemistry B;2024

4. Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy;Advanced Materials;2023-12-12

5. High CTCF expression mediated by FGD5-AS1/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer progression;Heliyon;2023-12